SCHEMBL3390551

SCHEMBL3390551

[CH2]CCCCCCCC(CC)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.44
SIGMAR1 Q99720 1/20 0.41
LMNA P02545 1/20 0.39
CCR5 P51681 1/20 0.38
HTR2A P28223 5/20 0.35
HRH1 P35367 5/20 0.35
TAAR1 Q96RJ0 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SLC7A5 Q01650 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17183751 1.00 NR1I2 (0.44) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL27567790 1.00 NR1I2 (0.44) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL11099949 1.00 NR1I2 (0.44) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL17183686 1.00 NR1I2 (0.44) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL9869713 0.98 SIGMAR1 (0.42) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL3385362 0.92 LMNA (0.42) NR1I2SIGMAR1LMNACCR5HTR2A
SCHEMBL8847425 0.88 HRH1 (0.39) SIGMAR1HTR2AHRH1TAAR1CYP2D6
SCHEMBL17183643 0.87 SIGMAR1 (0.40) NR1I2SIGMAR1LMNAHTR2AHRH1
SCHEMBL10597887 0.87 NR1I2 (0.43) NR1I2SIGMAR1HTR2ACYP19A1
SCHEMBL5933904 0.87 NR1I2 (0.43) NR1I2SIGMAR1HTR2ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010043633-A1 2H-PYRAZOLO [4,3-D]PYRIMIDIN-5-AMINE DERIVATIVES AS H4 HISTAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALLERGIC, IMMUNOLOGICAL AND INFLAMMATORY DISEASES PALAU PHARMA, S. A. (ES) 2010-04-22 WO disclosed